Tickers

1. Composite Trajectory Verdict

For a subscription-based software company like RBRK, the income statement (revenue growth, margin trajectory, and path to profitability) and cash flow statement (operating cash flow and free cash flow generation) carry the most weight, with the balance sheet providing critical context on liquidity and deferred revenue momentum.

Composite Trajectory: Improving

Revenue grew 48% year-over-year to $1.32 billion in FY2026 (10-K FY2026, Consolidated Statements of Operations) and 38% in Q2 FY2027 (10-Q 2026-07-31, Condensed Statements of Operations). Gross margin recovered to 80% in FY2026 from 70% in FY2025 (10-K FY2026, Results of Operations table). Operating loss narrowed dramatically from $1.13 billion in FY2025 to $345 million in FY2026 (10-K FY2026, Consolidated Statements of Operations). Operating cash flow turned strongly positive at $283 million in FY2026 and $159 million in the first six months of FY2027 (10-K FY2026, Consolidated Statements of Cash Flows; 10-Q 2026-07-31, Condensed Statements of Cash Flows). Free cash flow reached $238 million in FY2026 and $139 million in the first half of FY2027 (10-K FY2026, MD&A Non-GAAP Free Cash Flow table; 10-Q 2026-07-31, MD&A Free Cash Flow table). Cash, cash equivalents, and short-term investments grew to $1.68 billion at January 31, 2026 and $1.75 billion at July 31, 2026 (10-K FY2026, Balance Sheet; 10-Q 2026-07-31, Balance Sheet). Subscription ARR grew 34% to $1.46 billion at January 31, 2026 and 33% to $1.66 billion at July 31, 2026 (10-K FY2026, MD&A Key Business Metrics; 10-Q 2026-07-31, MD&A Key Business Metrics). All three statements show consistent improvement.

2. Red Flags

• Customer concentration: Two channel partners accounted for 27% and 32% of total revenue in FY2026 (10-K FY2026, Note 92 Concentration of revenue and accounts receivable).
• Non-recurring revenue from Subscription Credits: Approximately $70.2 million of subscription revenue in FY2026 came from material rights exercises/forfeitures, with benefits expected to “significantly reduce sequentially” in FY2027 (10-K FY2026, MD&A Comparison of Fiscal Years Ended January 31, 2026 and 2025).
• Persistent GAAP losses despite positive cash flow: Net loss of $349 million in FY2026 vs. operating cash flow of $283 million, driven largely by $329 million in stock-based compensation (10-K FY2026, Consolidated Statements of Operations; 10-K FY2026, Note 10 Stock-Based Compensation Expense).
• High and recurring stock-based compensation: SBC was $329 million in FY2026, down from $914 million in FY2025 (IPO-related) but still 25% of revenue (10-K FY2026, Note 10).
• Gross margin volatility: Gross margin swung from 77% (FY2024) to 70% (FY2025) to 80% (FY2026) due to revenue mix shifts and SBC fluctuations (10-K FY2026, Results of Operations table).
• Growing unrecognized tax benefits: Unrecognized tax benefits increased to $55.0 million at January 31, 2026 from $46.6 million and $31.3 million in prior years (10-K FY2026, Note 12).
• Accumulated deficit: $3.19 billion accumulated deficit at January 31, 2026, increasing from $2.84 billion (10-K FY2026, Balance Sheet).
• Convertible notes maturity: $1.15 billion principal due June 2030; though cash and investments cover this, it remains a long-term obligation (10-K FY2026, Note 8 Convertible Notes).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Total revenue increased 48% to $1.32 billion in FY2026 (10-K FY2026, Consolidated Statements of Operations) and 38% to $427 million in Q2 FY2027 (10-Q 2026-07-31, Condensed Statements of Operations). Subscription revenue, the core driver, grew 53% in FY2026 and 37% in Q2 FY2027. Gross margin expanded to 80% in FY2026 from 70% in FY2025, and held at 78-79% in recent quarters (10-K FY2026, Results of Operations table; 10-Q 2026-07-31, Condensed Statements of Operations). Total operating expenses decreased 20% year-over-year in FY2026 to $1.40 billion (from $1.75 billion) as IPO-related stock-based compensation normalized, though they remain at 106% of revenue (10-K FY2026, Consolidated Statements of Operations). Operating loss improved from $(1.13) billion to $(345) million in FY2026 and from $(94) million to $(72) million in Q2 FY2027 (10-K FY2026, Consolidated Statements of Operations; 10-Q 2026-07-31, Condensed Statements of Operations). Net loss followed a similar narrowing trend. Subscription ARR grew 34% to $1.46 billion (January 2026) and 33% to $1.66 billion (July 2026) with net retention over 119% (10-K FY2026, MD&A Key Business Metrics; 10-Q 2026-07-31, MD&A Key Business Metrics).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Net cash provided by operating activities rose from $48 million in FY2025 to $283 million in FY2026 (10-K FY2026, Consolidated Statements of Cash Flows) and from $104 million to $159 million for the comparable six-month periods (10-Q 2026-07-31, Condensed Statements of Cash Flows). Free cash flow (non-GAAP) improved from $22 million to $238 million in FY2026 and from $91 million to $139 million in the first half of FY2027 (10-K FY2026, MD&A Non-GAAP Free Cash Flow table; 10-Q 2026-07-31, MD&A Free Cash Flow table). The increase was driven by higher billings (deferred revenue increased $426 million in FY2026 and $85 million in the first half of FY2027) and improved operating leverage (10-K FY2026, MD&A Liquidity and Capital Resources; 10-Q 2026-07-31, MD&A Operating Activities). Cash, cash equivalents, and short-term investments grew from $712 million at January 31, 2025 to $1.68 billion at January 31, 2026 and $1.75 billion at July 31, 2026 (10-K FY2026, Balance Sheet; 10-Q 2026-07-31, Balance Sheet). Investing outflows reflect portfolio management (purchases/maturities of short-term investments) and acquisition spending ($21 million in FY2026, $24 million in first half FY2027). Financing inflows in FY2026 included $1.13 billion from convertible notes issuance; the first half of FY2027 showed a net outflow of $35 million primarily for tax withholding on equity awards.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Liquidity strengthened substantially: cash and short-term investments rose from $712 million (January 2025) to $1.68 billion (January 2026) to $1.75 billion (July 2026) (10-K FY2026, Balance Sheet; 10-Q 2026-07-31, Balance Sheet). Total deferred revenue (current + noncurrent) grew from $1.42 billion to $1.85 billion over FY2026 and to $1.93 billion at July 2026, reflecting contracted future revenue (10-K FY2026, Balance Sheet; 10-Q 2026-07-31, Balance Sheet). The term loan ($322 million at January 2025) was fully repaid in June 2025 and replaced with $1.15 billion of 0% convertible senior notes due 2030, extending maturity and eliminating cash interest (10-K FY2026, Note 8 Term Loan and Convertible Notes). Net carrying value of convertible notes was $1.13 billion at both January and July 2026. Stockholders’ deficit improved slightly from $(554) million to $(520) million despite a growing accumulated deficit ($(2.84) billion to $(3.19) billion), offset by APIC increases from equity issuances (10-K FY2026, Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit). Deferred commissions (current + noncurrent) grew from $224 million to $268 million, aligning with revenue growth (10-K FY2026, Balance Sheet).

6. Data Gaps

• No quarterly data for Q1 FY2026 (quarter ended April 30, 2025) or Q3 FY2025 (quarter ended October 31, 2024) to enable year-over-year comparisons for those quarters.
• No full-year FY2027 results; only first two quarters available.
• GAAP operating margin and net income margin trajectory to breakeven not disclosed.
• Detailed quarterly breakdown of Subscription Credits revenue impact beyond the FY2026 aggregate ($70.2 million).
• No disclosure of remaining performance obligations (RPO) quarterly trend beyond the annual snapshot in the 10-K ($2.40 billion at January 31, 2026).